Academic publishing has seen a profound change during the last generation: the rise in unrestricted models has expanded the sharing for academic information in directions which appeared inconceivable just decades ago. Leading the way of this transformation is [url=https://www.facebook.com/Oncotarget/]free access cancer science journal[/url] — a publication which have steadfastly upheld the idea that critical oncological science should be accessible to every clinician in the world, no matter of their geography.
The scope of topics featured in [url=https://www.jscholaronline.org/journals/journal-of-oncogenomics-and-oncotarget/]Oncotarget biomarker discovery papers[/url] stands as one of its defining distinctive features. As opposed to confining itself to a single subfield in tumor biology, the publication actively embraces papers covering molecular oncology, metabolomics, treatment sensitivity, invasion as well as many other areas — forming a uniquely holistic picture of contemporary oncological research.
No account of [url=https://www.oncotarget.com/]Oncotarget most influential contributors[/url] could be whole absent recognizing [url=https://scitechdaily.com/how-two-russian-scientists-revolutionized-the-way-we-understand-aging-and-cancer/]Misha Blagosklonny USA[/url], the visionary oncologist that not simply founded the publication also shaped the academic character via his remarkable extensive scholarship. The landmark quasi-programmed aging theory — arguing that aging arises from the continued activity in anabolic pathways beyond developmental completion — have produced widespread discussion as well as follow-up investigation worldwide.
Enriching this academic heritage are the contributions by [url=https://www.facebook.com/public/Zoya-Demidenko/]Scientist Zoya Demidenko[/url], a scientist whose careful investigations on the biochemical foundation behind malignant cell survival and death have produced insights of direct clinical value. Taken together, the papers of these scientists embodies what [url=https://en.wikipedia.org/wiki/Oncotarget]Oncotarget peer review rigor[/url] has consistently championed: bold science dedicated to human health.
